Richard E Parizek

Title: Richard E. Parizek: Innovator in Vaccine Development

Introduction

Richard E. Parizek, based in Lenexa, Kansas, is a notable inventor with a focus on vaccine innovation. He has been granted four patents that contribute significantly to the field of immunology and infectious disease prevention.

Latest Patents

Among his latest inventions is a multicomponent vaccine that combines clostridial and non-clostridial organisms in a low dose. This patent describes a vaccine formulation that includes a safe and immunogenically effective combination of protective antigens from both types of organisms, along with an adjuvant to enhance the immune response. Another significant patent involves the preparation and use of enzyme-detergent extracted Streptococcus. This innovative vaccine aims to combat infections caused by Streptococcus zooepidemicus, utilizing enzymatic digestion followed by detergent treatment to create an effective antigenic material combined with an appropriate adjuvant.

Career Highlights

Richard has worked with prominent companies in the biotech and pharmaceutical sectors, notably with Mobay Corporation and Bayer Corporation. His tenure in these organizations has provided him with a solid foundation in research and development, particularly in vaccine technologies.

Collaborations

Throughout his career, Richard has collaborated with several esteemed professionals, including Sharon A. Bryant and Karen K. Brown. These partnerships have facilitated the development of innovative solutions in vaccine research and enhance the overall impact of his inventions.

Conclusion

With a focus on advancing vaccine technology, Richard E. Parizek exemplifies the spirit of innovation in the field of immunology. His contributions through patenting novel vaccine formulations showcase his dedication to improving public health and combating infectious diseases.